Clinical Trial: Combined Antioxidant Therapy for Acute Myocardial Infarction

U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07776288) titled 'Combined Antioxidant Therapy for Acute Myocardial Infarction' on Aug. 10.

Brief Summary: The goal of this clinical trial is to learn if a combined antioxidant therapy (CAT) can reduce heart damage caused by the return of blood flow after blocked arteries are reopened in adults with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI). It will also learn about the safety of this treatment. The main questions it aims to answer are:

1. Does combined antioxidant therapy lower infarct size, measured by cardiac magnetic resonance imaging (CMR), compared with placebo?

2. Does combined a...